"10.1371_journal.pone.0071754","plos one","2013-08-05T00:00:00Z","Zhimin Li; Yushi Qiu; David Personett; Peng Huang; Brandy Edenfield; Jason Katz; Darius Babusis; Yang Tang; Michael A Shirely; Mehran F Moghaddam; John A Copland; Han W Tun","Department of Cancer Biology, Mayo Clinic, Jacksonville, Florida, United States of America; Department of Drug Metabolism and Pharmacokinetics, Celgene Corporation, San Diego, California, United States of America; Department of Hematology/Oncology, Mayo Clinic, Jacksonville, Florida, United States of America","Conceived and designed the experiments: ZL JAC HWT. Performed the experiments: ZL YQ DP PH BE. Analyzed the data: ZL YQ HWT. Contributed reagents/materials/analysis tools: PH HWT. Wrote the manuscript: ZL HWT. Performed the CNS pharmacokinetic experiments: JK DB YT MAS. Conceived and designed the CNS pharmacokinetic experiments: MFM.","The authors have the following interests. Jason Katz, Darius Babusis, Yang Tang, Michael A. Shirely and Mehran F. Moghaddam are employed by Celgene Corporation. Han W. Tun received a research grant from Celgene to support this research. The Pomalidomide used in this study is a Celgene product. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","08","Zhimin Li","ZL",12,TRUE,3,5,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
